PLEKHH3
geneOn this page
Also known as FLJ21019
Summary
PLEKHH3 (pleckstrin homology, MyTH4 and FERM domain containing H3, HGNC:26105) is a protein-coding gene on chromosome 17q21.2, encoding Pleckstrin homology domain-containing family H member 3 (Q7Z736).
Located in extracellular space.
Source: NCBI Gene 79990 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 155 total
- MANE Select transcript:
NM_024927
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26105 |
| Approved symbol | PLEKHH3 |
| Name | pleckstrin homology, MyTH4 and FERM domain containing H3 |
| Location | 17q21.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ21019 |
| Ensembl gene | ENSG00000068137 |
| Ensembl biotype | protein_coding |
| Entrez | 79990 |
Gene structure
Transcript identifiers
Ensembl transcripts: 17 — 11 protein_coding, 3 protein_coding_CDS_not_defined, 2 retained_intron, 1 nonsense_mediated_decay
ENST00000293349, ENST00000456950, ENST00000587627, ENST00000591022, ENST00000591196, ENST00000591476, ENST00000591490, ENST00000591544, ENST00000592974, ENST00000895611, ENST00000895612, ENST00000917129, ENST00000949018, ENST00000949019, ENST00000949020, ENST00000949021, ENST00000949022
RefSeq mRNA: 2 — MANE Select: NM_024927
NM_001411112, NM_024927
CCDS: CCDS11434, CCDS92327
Canonical transcript exons
ENST00000591022 — 13 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001059185 | 42670994 | 42671130 |
| ENSE00001219920 | 42669918 | 42670376 |
| ENSE00002911635 | 42676402 | 42676994 |
| ENSE00003459445 | 42673399 | 42673556 |
| ENSE00003460340 | 42671351 | 42671558 |
| ENSE00003494715 | 42673934 | 42674013 |
| ENSE00003515204 | 42670573 | 42670705 |
| ENSE00003559406 | 42669430 | 42669621 |
| ENSE00003569850 | 42673643 | 42673834 |
| ENSE00003571802 | 42672086 | 42672392 |
| ENSE00003621493 | 42673176 | 42673296 |
| ENSE00003625767 | 42667914 | 42668303 |
| ENSE00003641161 | 42674354 | 42674409 |
Expression profiles
Bgee: expression breadth ubiquitous, 202 present calls, max score 97.28.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 9.5444 / max 111.1305, expressed in 1564 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 166176 | 7.1551 | 1499 |
| 166177 | 1.8168 | 1115 |
| 166174 | 0.3062 | 137 |
| 166175 | 0.2663 | 119 |
Top tissues by expression
247 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| lower esophagus mucosa | UBERON:0035834 | 97.28 | gold quality |
| body of pancreas | UBERON:0001150 | 96.64 | gold quality |
| right coronary artery | UBERON:0001625 | 93.59 | gold quality |
| esophagus mucosa | UBERON:0002469 | 93.30 | gold quality |
| ectocervix | UBERON:0012249 | 93.23 | gold quality |
| body of stomach | UBERON:0001161 | 92.87 | gold quality |
| apex of heart | UBERON:0002098 | 92.30 | gold quality |
| endocervix | UBERON:0000458 | 92.14 | gold quality |
| left uterine tube | UBERON:0001303 | 91.74 | gold quality |
| tibial artery | UBERON:0007610 | 91.46 | gold quality |
| popliteal artery | UBERON:0002250 | 91.45 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 91.29 | gold quality |
| ascending aorta | UBERON:0001496 | 91.19 | gold quality |
| right ovary | UBERON:0002118 | 91.15 | gold quality |
| aorta | UBERON:0000947 | 91.12 | gold quality |
| thoracic aorta | UBERON:0001515 | 91.08 | gold quality |
| adenohypophysis | UBERON:0002196 | 90.76 | gold quality |
| mucosa of stomach | UBERON:0001199 | 90.72 | gold quality |
| left coronary artery | UBERON:0001626 | 90.43 | gold quality |
| esophagus | UBERON:0001043 | 90.40 | gold quality |
| body of uterus | UBERON:0009853 | 90.23 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 90.08 | gold quality |
| left ovary | UBERON:0002119 | 89.92 | gold quality |
| right adrenal gland | UBERON:0001233 | 89.88 | gold quality |
| skin of abdomen | UBERON:0001416 | 89.65 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 89.65 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 89.44 | gold quality |
| skin of leg | UBERON:0001511 | 89.37 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 89.31 | gold quality |
| gastrocnemius | UBERON:0001388 | 89.16 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.87 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
32 targeting PLEKHH3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4455 | 100.00 | 65.48 | 1587 |
| HSA-MIR-10401-5P | 99.99 | 65.79 | 948 |
| HSA-MIR-4514 | 99.99 | 67.10 | 1870 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-9983-3P | 99.94 | 71.48 | 3631 |
| HSA-MIR-6772-5P | 99.94 | 67.01 | 577 |
| HSA-MIR-6508-5P | 99.92 | 70.67 | 2465 |
| HSA-MIR-129-5P | 99.88 | 70.26 | 3273 |
| HSA-MIR-8067 | 99.86 | 69.59 | 2260 |
| HSA-MIR-609 | 99.82 | 64.26 | 505 |
| HSA-MIR-6885-3P | 99.75 | 70.36 | 3187 |
| HSA-MIR-1283 | 99.69 | 72.42 | 3009 |
| HSA-MIR-10394-5P | 99.65 | 66.83 | 1852 |
| HSA-MIR-1205 | 99.65 | 66.76 | 1826 |
| HSA-MIR-1249-5P | 99.61 | 66.55 | 2049 |
| HSA-MIR-6797-5P | 99.61 | 66.55 | 2084 |
| HSA-MIR-6132 | 99.60 | 65.83 | 1554 |
| HSA-MIR-6836-5P | 99.60 | 65.62 | 1538 |
| HSA-MIR-4762-5P | 99.57 | 68.54 | 1424 |
| HSA-MIR-7844-5P | 99.55 | 68.56 | 1428 |
| HSA-MIR-6722-3P | 99.45 | 67.62 | 1919 |
| HSA-MIR-1909-3P | 99.03 | 66.56 | 1662 |
| HSA-MIR-3926 | 98.95 | 69.26 | 1438 |
| HSA-MIR-6501-3P | 98.71 | 67.45 | 1480 |
| HSA-MIR-708-3P | 97.50 | 68.67 | 1082 |
| HSA-MIR-6748-3P | 97.20 | 65.66 | 836 |
| HSA-MIR-6895-5P | 97.05 | 64.96 | 522 |
| HSA-MIR-339-5P | 96.73 | 66.01 | 820 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | PLEKHH3 | ENSDARG00000070174 |
| mus_musculus | Plekhh3 | ENSMUSG00000035172 |
| rattus_norvegicus | Plekhh3 | ENSRNOG00000020238 |
Protein
Protein identifiers
Pleckstrin homology domain-containing family H member 3 — Q7Z736 (reviewed: Q7Z736)
All UniProt accessions (3): Q7Z736, K7EK04, X6R3U4
UniProt curated annotations — full annotation on UniProt →
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q7Z736-1 | 1 | yes |
| Q7Z736-2 | 2 | |
| Q7Z736-3 | 3 | |
| Q7Z736-4 | 4 |
RefSeq proteins (2): NP_001398041, NP_079203* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000299 | FERM_domain | Domain |
| IPR000857 | MyTH4_dom | Domain |
| IPR001849 | PH_domain | Domain |
| IPR011993 | PH-like_dom_sf | Homologous_superfamily |
| IPR014352 | FERM/acyl-CoA-bd_prot_sf | Homologous_superfamily |
| IPR019748 | FERM_central | Domain |
| IPR019749 | Band_41_domain | Domain |
| IPR035963 | FERM_2 | Homologous_superfamily |
| IPR038185 | MyTH4_dom_sf | Homologous_superfamily |
| IPR051724 | Actin_motor_Myosin | Family |
Pfam: PF00373, PF00784, PF21989
UniProt features (26 total): splice variant 7, compositionally biased region 4, region of interest 4, modified residue 3, domain 3, sequence conflict 2, signal peptide 1, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q7Z736-F1 | 74.53 | 0.43 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (3): 30, 638, 642
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 100 (showing top):
GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_UP, AP1_01, PAX4_01, GCANCTGNY_MYOD_Q6, TTTGTAG_MIR520D, AREB6_03, LINDGREN_BLADDER_CANCER_CLUSTER_3_DN, CREBP1_Q2, AP1_Q4_01, TGCTGAY_UNKNOWN, OCT1_03, BACH2_01, ARGGGTTAA_UNKNOWN, TGANTCA_AP1_C, NRF2_Q4
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (2): obsolete extracellular space (GO:0005615), cytoskeleton (GO:0005856)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
728 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PLEKHH3 | WDR49 | Q8IV35 | 577 |
| PLEKHH3 | GRIFIN | A4D1Z8 | 483 |
| PLEKHH3 | IFT70A | Q86WT1 | 458 |
| PLEKHH3 | PROB1 | E7EW31 | 458 |
| PLEKHH3 | FAM151A | Q8WW52 | 454 |
| PLEKHH3 | ASB15 | Q8WXK1 | 454 |
| PLEKHH3 | FRMD7 | Q6ZUT3 | 453 |
| PLEKHH3 | NUAK2 | Q9H093 | 399 |
| PLEKHH3 | HEATR5B | Q9P2D3 | 398 |
| PLEKHH3 | CNIH1 | O95406 | 387 |
| PLEKHH3 | PLEKHA2 | Q9HB19 | 383 |
| PLEKHH3 | PLEKHG1 | Q9ULL1 | 382 |
| PLEKHH3 | LMOD2 | Q6P5Q4 | 377 |
| PLEKHH3 | PLEKHB2 | Q96CS7 | 372 |
| PLEKHH3 | ZNF875 | P10072 | 353 |
IntAct
71 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| RFXANK | RFXAP | psi-mi:“MI:0914”(association) | 0.780 |
| GNAI3 | RGS12 | psi-mi:“MI:0914”(association) | 0.640 |
| NIPAL1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.640 |
| CXCR4 | TMEM120B | psi-mi:“MI:0914”(association) | 0.530 |
| MANSC1 | KLRG2 | psi-mi:“MI:0914”(association) | 0.530 |
| SLC31A1 | C2orf72 | psi-mi:“MI:0914”(association) | 0.530 |
| HAVCR2 | TCAF2 | psi-mi:“MI:0914”(association) | 0.530 |
| EFNB2 | FAM171A2 | psi-mi:“MI:0914”(association) | 0.530 |
| TGFBR2 | PIK3R2 | psi-mi:“MI:0914”(association) | 0.530 |
| PTGER3 | PIK3R2 | psi-mi:“MI:0914”(association) | 0.530 |
| IL4R | RHOBTB3 | psi-mi:“MI:0914”(association) | 0.530 |
| CLEC11A | VWA8 | psi-mi:“MI:0914”(association) | 0.530 |
| PTGES3 | AIP | psi-mi:“MI:0914”(association) | 0.530 |
| TMEM200A | STX6 | psi-mi:“MI:0914”(association) | 0.530 |
| CTDSP2 | ZMYM6 | psi-mi:“MI:0914”(association) | 0.530 |
| GABARAPL2 | PLEKHH3 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| PLEKHH3 | Dlg4 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| PB1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| MAPK4 | ILVBL | psi-mi:“MI:0914”(association) | 0.350 |
| Npc1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| PTGES3 | SBNO1 | psi-mi:“MI:0914”(association) | 0.350 |
| AVPR1B | KLRG2 | psi-mi:“MI:0914”(association) | 0.350 |
| EFNB1 | KRBA1 | psi-mi:“MI:0914”(association) | 0.350 |
| MAGEA8 | METTL15 | psi-mi:“MI:0914”(association) | 0.350 |
| CX3CL1 | FAM171A2 | psi-mi:“MI:0914”(association) | 0.350 |
| SKAP1 | MYO9A | psi-mi:“MI:0914”(association) | 0.350 |
| KCNE3 | PIK3R2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (77): PLEKHH3 (Affinity Capture-MS), PLEKHH3 (Affinity Capture-MS), PLEKHH3 (Affinity Capture-MS), PLEKHH3 (Affinity Capture-MS), PLEKHH3 (Affinity Capture-MS), PLEKHH3 (Affinity Capture-MS), PLEKHH3 (Affinity Capture-MS), PLEKHH3 (Affinity Capture-MS), PLEKHH3 (Affinity Capture-MS), PLEKHH3 (Affinity Capture-MS), PLEKHH3 (Affinity Capture-MS), PLEKHH3 (Affinity Capture-MS), PLEKHH3 (Affinity Capture-MS), PLEKHH3 (Affinity Capture-MS), PLEKHH3 (Affinity Capture-MS)
ESM2 similar proteins: A1L515, A4D2P6, A6QQD2, A8VU90, E1BDF2, O75808, O88995, P0CG25, P22083, Q0IIA6, Q2TA57, Q3B7L1, Q3MIP1, Q3U5Q7, Q3UR50, Q3UR97, Q3UV16, Q400G9, Q5BKX5, Q5EBM0, Q5GH72, Q5SZI1, Q5TM19, Q5U4P2, Q62994, Q659K9, Q6PRD1, Q7Z736, Q861W0, Q86UR1, Q8BNN1, Q8C0R7, Q8CG70, Q8IUW3, Q8IVL6, Q8N398, Q8NAG6, Q8NCW0, Q8R2H1, Q8VCE9
Diamond homologs: A0MP03, A5PF48, B2RTY4, D3ZJP6, E1BPK6, E7EZG2, E9Q634, F4HWY6, F4HXP9, F4I460, F4I507, F4I5Q6, F4IRU3, F4IUG9, F4IVR7, F4JM19, F4K0A6, F4K5J1, F8VQB6, K7U9N8, O00159, O00160, O08638, O74805, O88329, O94477, P05659, P08799, P10587, P19524, P21271, P22467, P24733, P32492, P34092, P34109, P35580, P35748, P35749, P42522
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
155 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 137 |
| Likely benign | 3 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2109 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:42669621:CCTG:C | acceptor_loss | 1.0000 |
| 17:42669622:CTGCA:C | acceptor_loss | 1.0000 |
| 17:42669623:T:C | acceptor_loss | 1.0000 |
| 17:42669926:G:C | donor_gain | 1.0000 |
| 17:42670992:A:AC | donor_gain | 1.0000 |
| 17:42670993:C:CC | donor_gain | 1.0000 |
| 17:42670993:CTT:C | donor_gain | 1.0000 |
| 17:42670995:T:TA | donor_gain | 1.0000 |
| 17:42671126:GCCAC:G | acceptor_gain | 1.0000 |
| 17:42671127:CCAC:C | acceptor_gain | 1.0000 |
| 17:42671127:CCACC:C | acceptor_gain | 1.0000 |
| 17:42671128:CAC:C | acceptor_gain | 1.0000 |
| 17:42671128:CACC:C | acceptor_gain | 1.0000 |
| 17:42671129:AC:A | acceptor_gain | 1.0000 |
| 17:42671130:CC:C | acceptor_gain | 1.0000 |
| 17:42671131:C:A | acceptor_loss | 1.0000 |
| 17:42671131:C:CC | acceptor_gain | 1.0000 |
| 17:42671352:T:TA | donor_gain | 1.0000 |
| 17:42671353:C:A | donor_gain | 1.0000 |
| 17:42671557:TC:T | acceptor_gain | 1.0000 |
| 17:42671558:CC:C | acceptor_gain | 1.0000 |
| 17:42671730:A:AC | donor_gain | 1.0000 |
| 17:42671731:C:CC | donor_gain | 1.0000 |
| 17:42673386:C:CA | donor_gain | 1.0000 |
| 17:42673394:TGTA:T | donor_loss | 1.0000 |
| 17:42673395:GTAC:G | donor_loss | 1.0000 |
| 17:42673396:TA:T | donor_loss | 1.0000 |
| 17:42673397:ACC:A | donor_loss | 1.0000 |
| 17:42673552:CAGAC:C | acceptor_gain | 1.0000 |
| 17:42673557:C:A | acceptor_loss | 1.0000 |
AlphaMissense
4981 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:42672232:C:A | K310N | 0.998 |
| 17:42672232:C:G | K310N | 0.998 |
| 17:42671466:G:T | P390H | 0.997 |
| 17:42672290:A:T | L291H | 0.997 |
| 17:42672142:G:C | S340R | 0.996 |
| 17:42672142:G:T | S340R | 0.996 |
| 17:42672144:T:G | S340R | 0.996 |
| 17:42673762:A:T | L124H | 0.996 |
| 17:42671466:G:C | P390R | 0.995 |
| 17:42672239:A:G | L308P | 0.995 |
| 17:42672349:G:C | F271L | 0.995 |
| 17:42672349:G:T | F271L | 0.995 |
| 17:42672351:A:G | F271L | 0.995 |
| 17:42673477:C:A | W190C | 0.995 |
| 17:42673477:C:G | W190C | 0.995 |
| 17:42673479:A:G | W190R | 0.995 |
| 17:42673479:A:T | W190R | 0.995 |
| 17:42671478:C:A | R386I | 0.994 |
| 17:42672290:A:G | L291P | 0.994 |
| 17:42673208:A:T | L246H | 0.994 |
| 17:42673241:A:G | L235P | 0.994 |
| 17:42673415:A:G | L211P | 0.994 |
| 17:42673762:A:G | L124P | 0.994 |
| 17:42672234:T:C | K310E | 0.993 |
| 17:42673241:A:T | L235Q | 0.993 |
| 17:42673693:A:T | L147H | 0.993 |
| 17:42669436:G:C | S733R | 0.992 |
| 17:42669436:G:T | S733R | 0.992 |
| 17:42669438:T:G | S733R | 0.992 |
| 17:42672158:A:G | L335P | 0.992 |
dbSNP variants (sampled 300 via entrez): RS1000189149 (17:42668552 G>C,T), RS1000284310 (17:42678731 C>A,T), RS1000558015 (17:42667517 C>A,G), RS1000615881 (17:42675917 T>A,C), RS1000645761 (17:42668813 T>C), RS1000967461 (17:42674066 C>T), RS1001550579 (17:42669774 C>A,T), RS1001626400 (17:42675565 GGCCCCGGCGGCGCAGCCC>G), RS1002115991 (17:42677031 G>C,T), RS1002428507 (17:42675518 C>A,G), RS1003118722 (17:42678110 C>A,G), RS1003160202 (17:42670496 T>G), RS1003352625 (17:42675737 C>A,G,T), RS1003583154 (17:42672005 G>A), RS1003908161 (17:42669411 A>G,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST008529_19 | Tea consumption | 2.000000e-06 |
| GCST009963_16 | Cataracts (operation) | 3.000000e-08 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0010091 | tea consumption measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
25 total (human), top 25 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| FR900359 | decreases phosphorylation | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| ICG 001 | increases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | increases expression | 1 |
| Irinotecan | increases expression | 1 |
| Fulvestrant | increases methylation | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Cisplatin | decreases expression | 1 |
| Estradiol | affects cotreatment, decreases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Methapyrilene | increases methylation | 1 |
| Phthalic Acids | increases methylation | 1 |
| Smoke | decreases expression | 1 |
| Tetrachlorodibenzodioxin | affects expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tunicamycin | increases expression | 1 |
| Urethane | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Thapsigargin | increases expression | 1 |
| Copper Sulfate | increases expression | 1 |
| Acrylamide | increases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): cataract